The anti-vaccine activist and President-elect Donald Trump's pick to lead the Department of Health comes from a famous ...
CEO of biotech company Ovid Therapeutics and a former chairman of biotech lobby group BIO told Reuters late last month.
Kennedy Jr. as Secretary of the Department of Health and Human Services, the response from the drug industry has remained ...
STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
Trump is expected to make Matt Gaetz his attorney general and Marco Rubio his secretary of state, and place Tulsi Gabbard, ...
Pharma and biotech stocks are down due to concerns over Robert F. Kennedy Jr. possibly taking the helm at HHS. Read more here ...
Trump's HHS nominee Robert F. Kennedy Jr., an anti-vaccine advocate calling for stricter pharma oversight, contrasts with ...
We need to act fast, and we want to have those people in place on Jan. 20, so that on Jan. 21, 600 people are going to walk into offices at NIH and 600 people are going to leave,” ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...